Single-cell transcriptomes reveal the heterogeneity and microenvironment of vestibular schwannoma
- PMID: 37862593
- PMCID: PMC10912001
- DOI: 10.1093/neuonc/noad201
Single-cell transcriptomes reveal the heterogeneity and microenvironment of vestibular schwannoma
Abstract
Background: Vestibular schwannoma (VS) is the most common benign tumor in the cerebellopontine angle and internal auditory canal. Illustrating the heterogeneous cellular components of VS could provide insights into its various growth patterns.
Methods: Single-cell RNA sequencing was used to profile transcriptomes from 7 VS samples and 2 normal nerves. Multiplex immunofluorescence was employed to verify the data set results. Bulk RNA sequencing was conducted on 5 normal nerves and 44 VS samples to generate a prediction model for VS growth.
Results: A total of 83 611 cells were annotated as 14 distinct cell types. We uncovered the heterogeneity in distinct VS tumors. A subset of Schwann cells with the vascular endothelial growth factor biomarker was significantly associated with fast VS growth through mRNA catabolism and peptide biosynthesis. The macrophages in the normal nerves were largely of the M2 phenotype, while no significant differences in the proportions of M1 and M2 macrophages were found between slow-growing and fast-growing VS. The normal spatial distribution of fibroblasts and vascular cells was destroyed in VS. The communications between Schwann cells and vascular cells were strengthened in VS compared with those in the normal nerve. Three cell clusters were significantly associated with fast VS growth and could refine the growth classification in bulk RNA.
Conclusions: Our findings offer novel insights into the VS microenvironment at the single-cell level. It may enhance our understanding of the different clinical phenotypes of VS and help predict growth characteristics. Molecular subtypes should be included in the treatment considerations.
Keywords: heterogeneity; molecular subtypes; single-cell RNA sequencing; tumor microenvironment; vestibular schwannoma (VS).
© The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
None declared.
Figures






References
-
- Evans DG, Moran A, King A, et al. . Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol. 2005;26(1):93–97. - PubMed
-
- Carlson ML, Link MJ.. Vestibular schwannomas. N Engl J Med. 2021;384(14):1335–1348. - PubMed
-
- Charabi S, Mantoni M, Tos M, Thomsen J.. Cystic vestibular schwannomas: neuroimaging and growth rate. J Laryngol Otol. 1994;108(5):375–379. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
- 81900928/National Natural Science Foundation of China
- 20191913/Shanghai Jiao Tong University
- YBKB201902/Biobank Project of Shanghai Ninth People's Hospital
- 2018SHZDZK05/Shanghai Municipal Science and Technology Major Project
- 14DZ2260300/Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases